Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-13

Clinical Trial Update: 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating desmopressin (DDAVP) to reduce bleeding during ultrasound-guided percutaneous renal biopsy. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (DDAVP) (Desmopressin)

Snippet

Sponsor: University of Bari | Conditions: Kidney Failure | Phase 4 | Status: COMPLETED | Results posted: 2015-01-13